ALECENSA vs IMKELDI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 30, 2026·How we rate

Possible drug interaction. ALECENSA and IMKELDI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALECENSA	IMKELDI
Rating	New	New
Pharmacy pays	—	~$25.80 /30
Type	RX	RX
Active ingredient	ALECTINIB HYDROCHLORIDE	IMATINIB MESYLATE
Manufacturer	Hoffmann La Roche	Shorla Oncology
Dosage forms	Capsule	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome

alecensa imkeldi

Rating

New

Pharmacy pays

—

~$25.80 /30

Type

Active ingredient

ALECTINIB HYDROCHLORIDE

IMATINIB MESYLATE

Manufacturer

Hoffmann La Roche

Shorla Oncology

Dosage forms

Capsule

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome

Frequently asked questions

What is the difference between Alecensa and Imkeldi?

Alecensa contains Alectinib Hydrochloride, while Imkeldi contains Imatinib Mesylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.